Sept 19 (Reuters) - AstraZeneca Plc AZN.L said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.
(Reporting by Rama Venkat in Bengaluru; Editing by Michael Perry)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In This StoryAZN
Latest Markets Videos
- Fed could cut rates in 2023, 2024 once inflation under control -Bullard
- US STOCKS-Wall St plunges as Snap's bleak forecast sparks selloff
- Former Fox News employee's suit accuses former anchorman of rape
- All Fed officials backed May rate hike, 'most' saw half-point rises in June and July, minutes show